BEAM Beam Therapeutics Inc Sotuvning operatsion marjasi

Beam Therapeutics Inc. - BEAM emitenti grafik logotipi

Beam Therapeutics Inc. (BEAM) Pfizer bilan hamkorlikda aniq terapiyalarni ishlab chiqmoqda. Kompaniya hozirda birlamchi klinik sinovlar bosqichida bo'lib, bu tadqiqot xarajatlarini vaqtincha oshirmoqda. Beam Therapeutics Inc. (BEAM) ning raqobatbardosh ustunligi xavfsiz, sayt-spetsifik DNK tahrirlash bo'yicha patentlarida namoyon bo'ladi. GURU.Markets grafigidagi operatsion rentabellik aktiv dinamikasini aks ettiradi, bunda -267.70 joriy darajani ko'rsatadi.

BEAM: beamtx.com Operatsion faoliyat rentabelligi 04.07.2022 - 20.11.2026

BEAM (Beam Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:Beam Tx, BEAM
beamtx.com asosiy tovari

Sektorni fundamental yetakchilarini aniqlash uchun tahlilchi operatsion marjani asosiy faoliyatdan olingan foydaning soliqlar va foizlargacha bo'lgan daromadga nisbati sifatida baholaydi. Ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini o'lchaydi, Beam Therapeutics Inc. (BEAM) holatida esa bu bevosita sertifikatlangan GMP ob'ektlarining optimallashtirilishiga bog'liq bo'lib, operatsion rentabellik trayektoriyasida kompaniyaning xarajatlarni oshirmasdan terapiya ishlab chiqarishini kengaytirish qobiliyatini aks ettiradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik